Insight into the role of DL-α-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments

Y. Mythili, Sudharsan Periyasamy Thandavan, P. Varalakshmi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cyclophosphamide (CP), a potent antitumor drug, is known to cause severe cardiotoxicity. The present study is aimed at evaluating the role of DL-α-Lipoic acid (LA) on the calcium responsiveness of cardiac myofilaments isolated from CP treated rats. Adult male Wistar rats were divided into four treatment groups. Two groups received single intraperitoneal injection of CP (200 mg/kg b.wt.) to induce cardiotoxicity, one of these groups received LA treatment (25 mg/kg b.wt. for 10 days). A vehicle treated control group and a LA drug control were also included. Cardiotoxicity was evident from increased levels of cardiac Troponin I in serum of CP treated rats. The pCa-actomyosin ATPase relationship of myofilaments demonstrated a rightward shift indicating diminished responsiveness in CP treated rats. The hill coefficient was reduced and the myofibrillar myosin Ca2+-ATPase and K+-(EDTA) activities were also significantly (P < 0.05) reduced. Ultrastuctural observations were also in agreement with the above abnormal changes, wherein loss of myofilaments occurred. LA effectively normalized these abnormalities and restored the cardiac function in CP administered rats.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalMolecular and Cellular Biochemistry
Volume289
Issue number1-2
DOIs
StatePublished - Sep 1 2006

Fingerprint

Thioctic Acid
Myofibrils
Cyclophosphamide
Rats
Calcium
Myosins
Troponin I
Calcium-Transporting ATPases
Drug and Narcotic Control
Intraperitoneal Injections
Edetic Acid
Antineoplastic Agents
Wistar Rats
Control Groups
Therapeutics
Serum
Pharmaceutical Preparations
Cardiotoxicity

Keywords

  • Cyclophosphamide
  • Heart
  • Lipoic acid
  • Myofibrillar calcium sensitivity
  • Ultrastructure

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Insight into the role of DL-α-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments. / Mythili, Y.; Periyasamy Thandavan, Sudharsan; Varalakshmi, P.

In: Molecular and Cellular Biochemistry, Vol. 289, No. 1-2, 01.09.2006, p. 31-37.

Research output: Contribution to journalArticle

@article{d51ae051ec9b42ff869ef660c78ca5a4,
title = "Insight into the role of DL-α-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments",
abstract = "Cyclophosphamide (CP), a potent antitumor drug, is known to cause severe cardiotoxicity. The present study is aimed at evaluating the role of DL-α-Lipoic acid (LA) on the calcium responsiveness of cardiac myofilaments isolated from CP treated rats. Adult male Wistar rats were divided into four treatment groups. Two groups received single intraperitoneal injection of CP (200 mg/kg b.wt.) to induce cardiotoxicity, one of these groups received LA treatment (25 mg/kg b.wt. for 10 days). A vehicle treated control group and a LA drug control were also included. Cardiotoxicity was evident from increased levels of cardiac Troponin I in serum of CP treated rats. The pCa-actomyosin ATPase relationship of myofilaments demonstrated a rightward shift indicating diminished responsiveness in CP treated rats. The hill coefficient was reduced and the myofibrillar myosin Ca2+-ATPase and K+-(EDTA) activities were also significantly (P < 0.05) reduced. Ultrastuctural observations were also in agreement with the above abnormal changes, wherein loss of myofilaments occurred. LA effectively normalized these abnormalities and restored the cardiac function in CP administered rats.",
keywords = "Cyclophosphamide, Heart, Lipoic acid, Myofibrillar calcium sensitivity, Ultrastructure",
author = "Y. Mythili and {Periyasamy Thandavan}, Sudharsan and P. Varalakshmi",
year = "2006",
month = "9",
day = "1",
doi = "10.1007/s11010-006-9144-4",
language = "English (US)",
volume = "289",
pages = "31--37",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Insight into the role of DL-α-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments

AU - Mythili, Y.

AU - Periyasamy Thandavan, Sudharsan

AU - Varalakshmi, P.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Cyclophosphamide (CP), a potent antitumor drug, is known to cause severe cardiotoxicity. The present study is aimed at evaluating the role of DL-α-Lipoic acid (LA) on the calcium responsiveness of cardiac myofilaments isolated from CP treated rats. Adult male Wistar rats were divided into four treatment groups. Two groups received single intraperitoneal injection of CP (200 mg/kg b.wt.) to induce cardiotoxicity, one of these groups received LA treatment (25 mg/kg b.wt. for 10 days). A vehicle treated control group and a LA drug control were also included. Cardiotoxicity was evident from increased levels of cardiac Troponin I in serum of CP treated rats. The pCa-actomyosin ATPase relationship of myofilaments demonstrated a rightward shift indicating diminished responsiveness in CP treated rats. The hill coefficient was reduced and the myofibrillar myosin Ca2+-ATPase and K+-(EDTA) activities were also significantly (P < 0.05) reduced. Ultrastuctural observations were also in agreement with the above abnormal changes, wherein loss of myofilaments occurred. LA effectively normalized these abnormalities and restored the cardiac function in CP administered rats.

AB - Cyclophosphamide (CP), a potent antitumor drug, is known to cause severe cardiotoxicity. The present study is aimed at evaluating the role of DL-α-Lipoic acid (LA) on the calcium responsiveness of cardiac myofilaments isolated from CP treated rats. Adult male Wistar rats were divided into four treatment groups. Two groups received single intraperitoneal injection of CP (200 mg/kg b.wt.) to induce cardiotoxicity, one of these groups received LA treatment (25 mg/kg b.wt. for 10 days). A vehicle treated control group and a LA drug control were also included. Cardiotoxicity was evident from increased levels of cardiac Troponin I in serum of CP treated rats. The pCa-actomyosin ATPase relationship of myofilaments demonstrated a rightward shift indicating diminished responsiveness in CP treated rats. The hill coefficient was reduced and the myofibrillar myosin Ca2+-ATPase and K+-(EDTA) activities were also significantly (P < 0.05) reduced. Ultrastuctural observations were also in agreement with the above abnormal changes, wherein loss of myofilaments occurred. LA effectively normalized these abnormalities and restored the cardiac function in CP administered rats.

KW - Cyclophosphamide

KW - Heart

KW - Lipoic acid

KW - Myofibrillar calcium sensitivity

KW - Ultrastructure

UR - http://www.scopus.com/inward/record.url?scp=33748304119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748304119&partnerID=8YFLogxK

U2 - 10.1007/s11010-006-9144-4

DO - 10.1007/s11010-006-9144-4

M3 - Article

VL - 289

SP - 31

EP - 37

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -